Previous close | 119.45 |
Open | 118.48 |
Bid | 116.20 x 100 |
Ask | 116.65 x 100 |
Day's range | 113.27 - 118.48 |
52-week range | 87.14 - 127.58 |
Volume | |
Avg. volume | 272,654 |
Market cap | 6.634B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 30.75 |
EPS (TTM) | 3.79 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 0.24 (0.20%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 133.25 |
Explore key insights from Ensign Group's robust Q1 2024 results, including increased earnings, revenue growth, and strategic expansions.
Comprehensive Analysis of Ensign Group's Financial Performance and Strategic Acquisitions
Conference Call and Webcast scheduled for tomorrow, May 2, 2024 at 10:00 am PTSAN JUAN CAPISTRANO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the first quarter of 2024, reporting GAAP diluted earnings per share of $1.19 a